miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response.
GSE26193_eset.Rd
Although there is evidence that redox regulation has an essential role in malignancies, its impact on tumor prognosis remains unclear. Here we show crosstalk between oxidative stress and the miR-200 family of microRNAs that affects tumorigenesis and chemosensitivity. miR-141 and miR-200a target p38?? and modulate the oxidative stress response. Enhanced expression of these microRNAs mimics p38?? deficiency and increases tumor growth in mouse models, but it also improves the response to chemotherapeutic agents. High-grade human ovarian adenocarcinomas that accumulate miR-200a have low concentrations of p38?? and an associated oxidative stress signature. The miR200a-dependent stress signature correlates with improved survival of patients in response to treatment. Therefore, the role of miR-200a in stress could be a predictive marker for clinical outcome in ovarian cancer. In addition, although oxidative stress promotes tumor growth, it also sensitizes tumors to treatment, which could account for the limited success of antioxidants in clinical trials.
Usage
data( GSE26193_eset )
Format
experimentData(eset):
Experiment data
Experimenter name: Mateescu B, Batista L, Mariani O, Meyniel J, Cottu PH, Sastre-Garau X, Mechta-Grigoriou F
Laboratory: Mateescu, Mechta-Grigoriou 2011
Contact information:
Title: miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response.
URL:
PMIDs: 22101765
Abstract: A 149 word abstract is available. Use 'abstract' method.
Information is available on: preprocessing
notes:
platform_title:
[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array
platform_shorttitle:
Affymetrix HG-U133Plus2
platform_summary:
hgu133plus2
platform_manufacturer:
Affymetrix
platform_distribution:
commercial
platform_accession:
GPL570
platform_technology:
in situ oligonucleotide
Preprocessing: frma
featureData(eset):
An object of class 'AnnotatedDataFrame'
featureNames: A1BG A1BG-AS1 ... ZZZ3 (19816 total)
varLabels: probeset gene
varMetadata: labelDescription
Details
assayData: 19816 features, 107 samples
Platform type: hgu133plus2
Overall survival time-to-event summary (in years):
Call: survfit(formula = Surv(time, cens) ~ -1)
records n.max n.start events median 0.95LCL 0.95UCL
107.00 107.00 107.00 76.00 3.05 2.50 4.56
---------------------------
Available sample meta-data:
---------------------------
alt_sample_name:
Length Class Mode
107 character character
sample_type:
tumor
107
histological_type:
clearcell endo mucinous other ser
6 8 8 6 79
summarygrade:
high low
67 40
summarystage:
early late
31 76
tumorstage:
1 2 3 4
20 11 59 17
substage:
a b c NA's
16 12 62 17
grade:
1 2 3
7 33 67
days_to_tumor_recurrence:
Min. 1st Qu. Median Mean 3rd Qu. Max.
3.0 340.5 584.0 1108.0 1525.0 7386.0
recurrence_status:
norecurrence recurrence
27 80
days_to_death:
Min. 1st Qu. Median Mean 3rd Qu. Max.
3 668 1096 1520 2220 7386
vital_status:
deceased living
76 31
batch:
Length Class Mode
107 character character
uncurated_author_metadata:
Length Class Mode
107 character character